L-161,982 – 5 mg

Brand:
Cayman
CAS:
147776-06-5
Storage:
-20
UN-No:
Non-Hazardous - /

Prostaglandin E2 (PGE2) exerts its effects through four separate G coupled-protein receptors (EP1-4).{1422} L-161,982 is a potent and selective EP4 receptor antagonist. It demonstrates selective binding to human EP4 receptors with a Ki value of 0.024 µM compared to other receptors of the prostanoid family, EP1, EP2, EP3, DP, FP, and IP, with Ki values of 17, 23, 1.9, 5.1, 5.6, and 6.7 µM, respectively.{11629} L-161,982 at 10 mg/kg/day suppresses PGE2-stimulated bone formation in young rats{11629} and at 100 nM reverses the anti-inflammatory action of PGE2 in LPS-activated human macrophages.{10774} At 10 µM L-161982 blocks PGE2-induced cell proliferation in HCA-7 colon cancer cells.{16761}  

 

Available on backorder

SKU: 10011565 - 5 mg Category:

Description

A potent and selective EP4 receptor antagonist (Ki = 24 nM); reverses the anti-inflammatory action of PGE2 in LPS – activated human macrophages at 100 nM


Formal name: N-[[4′-[[3-butyl-1,5-dihydro-5-oxo-1-[2-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-4-yl]methyl][1,1′-biphenyl]-2-yl]sulfonyl]-3-methyl-2-thiophenecarboxamide

Synonyms: 

Molecular weight: 654.7

CAS: 147776-06-5

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway